Beta defensin-1 gene polymorphisms and susceptibility to Atypical Squamous Cells of Undetermined Significance lesions in Italian gynecological patients

Journal of Medical Virology

Volumn 86, Issue 12, 2014, Pages 1999-2004

  Casalicchio, Giorgia ^a   Freato, Nadia ^b   Maestri, Iva ^c   Comar, Manola ^a,b   Crovella, Sergio ^a,b   Segat, Ludovica ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

ASCUS; DEFB1; Functional polymorphisms; Host genetic factors; Human papillomavirus

Indexed keywords

BETA DEFENSIN 1; GENOMIC DNA; VIRUS DNA; 5' UNTRANSLATED REGION; BETA DEFENSIN; DEFB1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; DNA SEQUENCE; FEMALE; FUNCTIONAL POLYMOPHISM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; WART VIRUS; 5' UNTRANSLATED REGION; ADOLESCENT; COMPLICATION; GENETICS; ITALY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; BETA-DEFENSINS; FEMALE; GENOTYPE; HUMANS; ITALY; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84911806957     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23878     Document Type: Article

References (36)

1. Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ. 2013. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 3:CD008054.
2. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26:K1-K16.
3. Bose SK, Gibson W, Bullard RS, Donald CD. 2009. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer Mol Immunol 46:1140-1148.
4. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, Crovella S. 2004. A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with hiv-1 infection in Italian children. AIDS 18:1598-1600.
5. Broder S. 1992. From the National Institutes of Health. Rapid communication: The Bethesda System for reporting cervical/vaginal cytologic diagnoses-Report of the 1991 Bethesda Workshop. JAMA 267:1892.
6. Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, Hazen-Martin DJ, Lage JM, Keane TE, Ganz TA, Donald CD. 2008 Functional analysis of the host defense peptide human beta defensin-1: New insight into its potential role in cancer. Mol Immunol 45:839-848.
7. Chong KT, Xiang L, Wang X, Jun EL, Xi LF, Schweinfurth JM. 2006. High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions. Virol J 3:75.
8. Comar M, Iannacone MR, Casalicchio G, McKay-Chopin S, Tommasino M, Gheit T. 2012. Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative Pap test results and atypical squamous cells of undetermined significance. J Clin Microbiol 50:4041-4046.
9. Erhart W, Alkasi Ö, Brunke G, Wegener F, Maass N, Arnold N, Arlt A, Meinhold-Heerlein I. 2011. Induction of human β-defensins and psoriasin in vulvovaginal human papillomavirus-associated lesions. J Infect Dis 204:391-399.
10. Galani E, Christodoulou C. 2009. Human papilloma viruses and cancer in the post-vaccine era. Clin Microbiol Infect 15:977-981.
11. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. Lyon, France: WHO.
12. Izadi Mood A, Haratian A. 2004. Atypical squamous cells of undetermined Significance: A cytohistologic study. Acta Med Iran 4:295-299.
13. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. 2003. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: High-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 41:90-96.
14. Milanese M, Segat L, Crovella S. 2007. Transcriptional effect of DEFB1 gene 5′ untranslated region polymorphisms. Cancer Res 67:5997.
15. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. 2003. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
16. Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
17. Naslavsky MS, Crovella S, Lima Filho JL, Rocha CR. 2010. The sound of silence: Human beta-defensin-1 gene untranslated SNPs change the predicted mRNA secondary structure in a length-dependent manner. Immunol Lett 129:53-55.
18. National Cancer Institute Workshop. 1992. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol 16:914-916.
19. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62:ii17-L ii21.
20. Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. 2009. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 45:526-530.
21. Pieralli A, Fallani MG, Penna C, Fambrini M, Tarani S, Marchionni M. 2007. L'azione immunomodulante del Beta-glucano come adiuvante nella regressione delle alterazioni citologiche cervicali di basso grado (ASCUS e LSIL) Ginecologia online.
22. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. 2007. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195:1582-1589.
23. Prado Montes de Oca E. 2011. Human polymorphisms as clinical predictors in leprosy. J Trop 2011:923943.
24. Prado-Montes de Oca E. 2010. Human beta-defensin 1: A restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol 42:800-804.
25. Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. 2009. Perinatal transmission of human papillomavirus DNA. Virol J 6:83.
26. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
27. Smith MC, Keech SE, Perryman K, Soutter WP. 2006. A long-term study of women with normal colposcopy after referral with low-grade cytological abnormalities. BJOG 113:1321-1328.
28. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N, Forum Group Members; Bethesda 2001 Workshop. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114-2119.
29. Sorensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA, Ganz T. 2005. Differential regulation of betadefensin expression in human skin by microbial stimuli. J Immunol 174:4870-4879.
30. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. 2006. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: Control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 66:8542-8549.
31. Syrjanen K. 2008. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors. Eur J Gynaecol Oncol 29:205-221.
32. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
33. Wenghoefer M, Pantelis A, Dommisch H, Götz W, Reich R, Bergé S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse S, Fischer HP, Novak N, Winter J. 2008. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 8:290.
34. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ. 1999. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528.
35. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. 2007. Defensin participation in innate and adaptive immunity. Curr Pharm Des 13:3131-3139.
36. Zhu BD, Feng Y, Huang N, Wu Q, Wang BY. 2003. Mycobacterium bovis bacilli Calmette-Guerin (BCG) enhances human beta-defensin-1 gene transcription in human pulmonary gland epithelial cells. Acta Pharmacol Sin 24:907-912.